Anti-Cancer Agents in Medicinal Chemistry
Title:Editorial (Hot Topic: Survival Signaling Through Focal Adhesion Kinase in Tumors)
Volume: 13 Issue: 4
Author(s): Vita M. Golubovskaya
Affiliation:
Export Options
About this article
Cite this article as:
M. Golubovskaya Vita, Editorial (Hot Topic: Survival Signaling Through Focal Adhesion Kinase in Tumors), Anti-Cancer Agents in Medicinal Chemistry 2013; 13 (4) . https://dx.doi.org/10.2174/1871520611313040001
DOI https://dx.doi.org/10.2174/1871520611313040001 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
21
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Telomeres and their Role in Aging and Longevity
Current Vascular Pharmacology Gene Therapy in the Transplantation of Allogeneic Organs and Stem Cells
Current Gene Therapy Gender Disparity in Pediatric Diseases
Current Molecular Medicine Early Vascular Ageing (EVA): Definitions and Clinical Applicability
Current Hypertension Reviews Transition in Infant and Young Child Feeding Practices in India
Current Diabetes Reviews The Impact of Probiotic on Gut Health
Current Drug Metabolism The Application of Single Nucleotide Polymorphism Microarrays in Cancer Research
Current Genomics Mitochondrial Alterations and Neuropsychiatric Disorders
Current Medicinal Chemistry HR-MAS NMR Spectroscopy: A Practical Guide for Natural Samples
Current Organic Chemistry Advances in Whole Genome Sequencing Technology
Current Pharmaceutical Biotechnology Pharmacological Innovations for Posttraumatic Stress Disorder and Medication- Enhanced Psychotherapy
Current Pharmaceutical Design Current Overview of Inorganic Nanoparticles for the Treatment of Central Nervous System (CNS) Diseases
Current Nanomaterials Damage-Associated Molecular Patterns – Emerging Targets for Biologic Therapy of Childhood Arthritides
Inflammation & Allergy - Drug Targets (Discontinued) Encapsulation of Imatinib in Targeted KIT-5 Nanoparticles for Reducing its Cardiotoxicity and Hepatotoxicity
Anti-Cancer Agents in Medicinal Chemistry Functions of the Third Intracellular Loop of the Human Melanocortin-3 Receptor
Current Pharmaceutical Design Ketogenic Diets in the Treatment of Epilepsy
Current Pharmaceutical Design The Endocrine System and Sarcopenia: Potential Therapeutic Benefits
Current Aging Science Pharmacogenetics, Pharmacogenomics and Epigenetics of Nrf2-regulated Xenobioticmetabolizing Enzymes and Transporters by Dietary Phytochemical and Cancer Chemoprevention
Current Drug Metabolism Natural Products as Anticancer Agents
Current Drug Targets Secondary Radiation-Induced Bone Tumours Demonstrate a High Degree of Genomic Instability Predictive of a Poor Prognosis
Current Genomics